| RS1576367919 |
STAG1
|
Health Risk |
Likely pathogenic |
— |
| RS1576373932 |
FOXP1
|
Health Risk |
Pathogenic |
Intellectual disability-severe speech delay-mild dysmorphism syndrome, Intellectual disability-severe speech delay-mild dysmorphism syndrome |
| RS1576379332 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS1576387876 |
MRAS
|
Health Risk |
Likely pathogenic |
Noonan syndrome 11, RASopathy |
| RS1576387885 |
MRAS
|
Health Risk |
Likely pathogenic |
Noonan syndrome 11, RASopathy |
| RS1576390243 |
SMARCC1
|
Health Risk |
Likely pathogenic; risk factor |
Congenital hydrocephalus, Hydrocephalus |
| RS1576397633 |
PCCB
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1576401641 |
MYLK
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 7 |
| RS1576402791 |
TTN
|
Health Risk |
Pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1576402832 |
PCCB
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1576408050 |
SMARCC1
|
Health Risk |
Likely pathogenic |
Congenital hydrocephalus, Congenital hydrocephalus |
| RS1576408057 |
SMARCC1
|
Health Risk |
Likely pathogenic; risk factor |
Congenital hydrocephalus, Hydrocephalus |
| RS1576412227 |
SMARCC1
|
Health Risk |
Likely pathogenic |
Congenital hydrocephalus, Congenital hydrocephalus |
| RS1576415390 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1576422965 |
MYLK
|
Health Risk |
Pathogenic |
Aortic aneurysm, familial thoracic 7 |
| RS1576423296 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS1576426439 |
SMARCC1
|
Health Risk |
Likely pathogenic |
Congenital hydrocephalus, Congenital hydrocephalus |
| RS1576428862 |
COL4A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant Alport syndrome, Autosomal recessive Alport syndrome |
| RS1576428882 |
SLCO2A1
|
Health Risk |
Pathogenic |
Hypertrophic osteoarthropathy, primary |
| RS1576441321 |
TTN
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1576444504 |
SLCO2A1
|
Health Risk |
Likely pathogenic |
Hypertrophic osteoarthropathy, primary |
| RS1576457869 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1576457876 |
COL4A4
|
Health Risk |
Pathogenic |
Autosomal dominant Alport syndrome, Autosomal dominant Alport syndrome |
| RS1576461647 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1576462792 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Ehlers-Danlos syndrome |
| RS1576463100 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1576463632 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1576463663 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1576465155 |
COL3A1
|
Health Risk |
Pathogenic |
Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome, Ehlers-Danlos syndrome |
| RS1576465252 |
ARL6
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 3, Retinitis pigmentosa 55 |
| RS1576465489 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1576467025 |
SLCO2A1
|
Health Risk |
Likely pathogenic |
Hypertrophic osteoarthropathy, primary |
| RS1576467133 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1576467144 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1576467391 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1576468160 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1576468332 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1576468385 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1576468562 |
COL3A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1576469513 |
ZIC1
|
Health Risk |
Likely pathogenic |
— |
| RS1576469579 |
FOXL2
|
Health Risk |
Pathogenic |
Blepharophimosis, ptosis |
| RS1576470032 |
COL3A1
|
Health Risk |
Likely pathogenic |
— |
| RS1576470734 |
ZIC1
|
Health Risk |
Pathogenic |
— |
| RS1576470749 |
ZIC1
|
Health Risk |
Pathogenic |
Structural brain anomalies with impaired intellectual development and craniosynostosis, Structural brain anomalies with impaired intellectual development and craniosynostosis |
| RS1576471840 |
COL3A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1576471851 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, type 4 |
| RS1576472316 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1576472890 |
COL3A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1576473569 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Ehlers-Danlos syndrome |
| RS1576473641 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1576474929 |
COL3A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, type 4 |
| RS1576484361 |
CACNA1D
|
Health Risk |
Likely pathogenic |
Sinoatrial node dysfunction and deafness, Sinoatrial node dysfunction and deafness |
| RS1576486164 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS1576493931 |
COL5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS1576502045 |
COL5A2
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1576517390 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1576517517 |
COL5A2
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1576517675 |
DHX30
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with severe motor impairment and absent language, Neurodevelopmental disorder with severe motor impairment and absent language |
| RS1576520630 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS1576521473 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1576526285 |
ADCY5
|
Health Risk |
Likely pathogenic |
Dyskinesia with orofacial involvement, autosomal dominant |
| RS1576540110 |
TTN
|
Health Risk |
Pathogenic |
— |
| RS1576543528 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1576550450 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1576552712 |
BFSP2
|
Health Risk |
Pathogenic |
Cataract 12 multiple types, Cataract 12 multiple types |
| RS1576559094 |
IQCB1
|
Health Risk |
Pathogenic |
Renal dysplasia and retinal aplasia, Renal dysplasia and retinal aplasia |
| RS1576571835 |
COL4A4
|
Health Risk |
Pathogenic |
Autosomal dominant Alport syndrome, Autosomal dominant Alport syndrome |
| RS1576600442 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1576606182 |
ADCY5
|
Health Risk |
Likely pathogenic |
Dyskinesia with orofacial involvement, autosomal dominant |
| RS1576606282 |
ADCY5
|
Health Risk |
Likely pathogenic |
Dyskinesia with orofacial involvement, autosomal dominant |
| RS1576608220 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS1576608720 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1576610000 |
P4HTM
|
Health Risk |
Pathogenic |
Hypotonia, hypoventilation |
| RS1576623358 |
CLRN1
|
Health Risk |
Pathogenic |
— |
| RS1576623563 |
CLRN1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1576631624 |
CLRN1
|
Health Risk |
Pathogenic |
Usher syndrome type 3, Usher syndrome type 3 |
| RS1576651623 |
CLRN1
|
Health Risk |
Pathogenic |
Usher syndrome type 3, Usher syndrome type 3 |
| RS1576656734 |
STAG1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 47 |
| RS1576660495 |
NPHP3
|
Health Risk |
Pathogenic |
Nephronophthisis 3, NPHP3-related Meckel-like syndrome |
| RS1576682880 |
NPHP3
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis 3 |
| RS1576682959 |
NPHP3
|
Health Risk |
Likely pathogenic |
— |
| RS1576685753 |
TTN
|
Health Risk |
Likely pathogenic |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS1576687466 |
HPS3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hermansky-Pudlak syndrome 3, Hermansky-Pudlak syndrome 3 |
| RS1576691273 |
CAMTA1
|
Health Risk |
Pathogenic |
Cerebellar dysfunction with variable cognitive and behavioral abnormalities, Cerebellar dysfunction with variable cognitive and behavioral abnormalities |
| RS1576695735 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1576695913 |
HPS3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hermansky-Pudlak syndrome, Hermansky-Pudlak syndrome 3 |
| RS1576704514 |
ADCY5
|
Health Risk |
Likely pathogenic |
Dyskinesia with orofacial involvement, autosomal dominant |
| RS1576704575 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1576708708 |
HPS3
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome, Hermansky-Pudlak syndrome 3 |
| RS1576721522 |
GFM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS1576723006 |
GFM1
|
Health Risk |
Pathogenic |
— |
| RS1576741993 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1576742510 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS1576744250 |
GATA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Deafness-lymphedema-leukemia syndrome, Monocytopenia with susceptibility to infections |
| RS1576744275 |
GATA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Deafness-lymphedema-leukemia syndrome, GATA2 deficiency with susceptibility to MDS/AML |
| RS1576744529 |
GATA2
|
Health Risk |
Likely pathogenic |
GATA2 deficiency with susceptibility to MDS/AML, Deafness-lymphedema-leukemia syndrome |
| RS1576744575 |
GATA2
|
Health Risk |
Likely pathogenic |
— |
| RS1576744594 |
GATA2
|
Health Risk |
Likely pathogenic |
— |
| RS1576744604 |
GATA2
|
Health Risk |
Likely pathogenic |
— |
| RS1576745225 |
GATA2
|
Health Risk |
Pathogenic |
Myelodysplastic syndrome, GATA2 deficiency with susceptibility to MDS/AML |